BMC pulmonary medicine
Efficacy and safety of anlotinib combined with immune checkpoint inhibitors in the treatment of extensive-stage small cell lung cancer: a meta-analysis based on real-world data.
Yuying Yan, Xuebin Yang, Xu Yan, Xin Wang, Zhaoshuai Ji
Published: 202510.1186/s12890-025-04018-9
No abstract available for this study.